
China Study Confirms CanSinoBIO’s Low‑Dose COVID‑19 Vaccine Is Safe for Children
CanSinoBIO's Covid-19 vaccine, tested at lower dosage, safe for children: Study, China News,BEIJING – CanSino Biologics' (CanSinoBIO) single-dose Covid-19 vaccine, given at a lower dosage than that for adults, is safe and triggers an immune response in children aged six to 17, results from